Quote from sam Cena on May 28, 2022, 11:09 am

Diethylpropion HCL tablets are an oral, sympathomimetic amine that is used as an anorexiant agent. It is structurally and chemically related to the amphetamines. The pharmacologic effects of diethylpropion are also similar to amphetamines. Diethylpropion tablets are utilized in the short-term (up to 12 weeks) management of obesity. Clinical trials report greater weight loss in adult obese subjects treated with dietary management and anorexiants versus patients treated with diet and placebo alone. Weight loss is generally greatest in the first weeks of therapy and decreases in succeeding weeks. Diethylpropion is recommended for short term treatment of obesity; however, longer periods of therapy, up to 25 weeks, may be safely and successfully utilized without the development of tolerance or drug dependence. Diethylpropion HCL tablets were approved by the FDA in 1959 and is available in both immediate-release and sustained-release tablets. It is only indicated for use as monotherapy.

For more info diethylpropion hcl 75 mg.